New Key Statistics Module, Z-Score and F-Score
OTCPK:BXPHF Key Ratios
| Market Cap $ M | 460.09 |
| Enterprise Value $ M | 454.22 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 46.35 |
| Price/Book | 6.25 |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.007 |
| Beneish M-Score | 1.04 |
| 10-y EBITDA Growth Rate % | 6.40 |
| 5-y EBITDA Growth Rate % | 14.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -48.45 |
| EV-to-EBITDA | -48.71 |
| PEG | -- |
| Shares Outstanding M | 1,814.04 |
| Net Margin (%) | -2,303.99 |
| Operating Margin % | -2,567.94 |
| Pre-tax Margin (%) | -2,303.99 |
| Quick Ratio | 21.89 |
| Current Ratio | 22.21 |
| ROA % (ttm) | -22.49 |
| ROE % (ttm) | -23.50 |
| ROIC % (ttm) | -66.54 |
| Dividend Yield % | -- |
| Altman Z-Score | 108.68 |
BXPHF Number of Guru Trades
BXPHF Volume of Guru Trades
Gurus Latest Trades with OTCPK:BXPHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:BXPHF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Botanix Pharmaceuticals Ltd Insider Transactions
No Available Data
News about OTCPK:BXPHF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers